Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

Press releases published on October 6, 2026

Akebia Therapeutics Announces Late-Breaking VOICE Trial Presentation and Posters on Akebia’s Rare Kidney Pipeline at ASN Kidney Week 2026
Madrigal Announces Publication in the Journal of Hepatology Demonstrating Consistent Rezdiffra Efficacy Across Common MASH Genetic Risk Variants
ArriVent Announces Program Update from the Phase 3 FURVENT Trial of Firmonertinib in First-Line EGFR Exon 20 Insertion Mutant NSCLC
Porch Light Health Awarded $6.6 Million Through Colorado Rural Health Transformation Program
TSC Life Receives FDA Clearance for Mistral-Air® MA1400 Forced Air Warming System
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Cerenome Launches CNSide® CSF Molecular Profile Tests
BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia
ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer
Zenas BioPharma to Host Virtual R&D Event
Ocugen Appoints Industry Executive Jolanda Crombach General Manager of European Affiliate
Why Do You Keep Gaining Weight Back After Losing It
F2G Announces Abstracts Accepted for Oral and Poster Presentation at IDWeek 2026
Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel
Shopify to Announce Third-Quarter 2026 Financial Results
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for BEQALZI™ (sonrotoclax)
Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Brief Comoros

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.